Literature DB >> 22722960

Association between psychopathology and problems of psychosocial functioning in the long-term outcome of patients diagnosed with schizophrenic, schizoaffective and affective disorders.

Ronald Bottlender1, Anton Strauss, Hans-Jürgen Möller.   

Abstract

Mental health problems do significantly impact on a person's functioning. In the past, problems with psychosocial functioning were mainly associated with the diagnoses of schizophrenia. However, nowadays it is clear that impaired psychosocial functioning is also a common phenomenon in people suffering from affective disorders. Only few studies have investigated psychosocial functioning in patients with affective, schizoaffective and schizophrenic disorders in the long-term and in a comparative approach. In the present study, we analysed the association between psychopathology and psychosocial functioning. This question is relevant as symptom remission and sufficient levels of functioning are considered as important indicators of patients' recovery from their mental health problems. The here reported findings refer to the data of a sample of 177 patients with life-time diagnoses belonging to the schizophrenic, schizoaffective or affective spectrum according to the ICD-10 criteria. Psychopathological, socio-demographic and other illness-related variables were assessed at the index hospitalisation and at the 15-year follow-up evaluation. In the present study, psychopathology is focused on data assessed with the PANSS (Positive and Negative Syndrome Scale). Information about patients' psychosocial functioning was assessed by using a modified and extended version of the WHO disability assessment scale (WHO-DAS-M). The association between psychosocial functioning and psychopathology was analysed by correlation analyses with the total sample and diagnostic subsamples. The consistency of correlations across the diagnostic groups and domains of psychosocial functioning was calculated. Findings revealed for all diagnostic groups that higher levels of psychopathology were associated with higher levels of problems in psychosocial functioning in various domains. Though there seem to be some differences between psychopathological dimensions and their effects on different aspects of psychosocial functioning, findings across the three diagnostic categories were fairly consistent. The present findings do highlight the importance of symptom remission in achieving social recovery and preventing impairment in psychosocial functioning in all major psychiatric disorders.

Entities:  

Mesh:

Year:  2012        PMID: 22722960     DOI: 10.1007/s00406-012-0335-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  24 in total

1.  Neurocognitive and social functioning in schizophrenia.

Authors:  J Addington; D Addington
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

Review 2.  Social functioning as an outcome measure in schizophrenia studies.

Authors:  T Burns; D Patrick
Journal:  Acta Psychiatr Scand       Date:  2007-10-17       Impact factor: 6.392

3.  Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept?

Authors:  Philip D Harvey; Alan S Bellack
Journal:  Schizophr Bull       Date:  2009-01-06       Impact factor: 9.306

4.  How are we assessing functioning in schizophrenia? A need for a consensus approach.

Authors:  J Peuskens; P Gorwood
Journal:  Eur Psychiatry       Date:  2011-05-31       Impact factor: 5.361

5.  The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity.

Authors:  Hans-Jürgen Möller; Markus Jäger; Michael Riedel; Michael Obermeier; Anton Strauss; Ronald Bottlender
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-05-22       Impact factor: 5.270

6.  Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres.

Authors:  D Wiersma; J Wanderling; E Dragomirecka; K Ganev; G Harrison; W An Der Heiden; F J Nienhuis; D Walsh
Journal:  Psychol Med       Date:  2000-09       Impact factor: 7.723

7.  Relationship of cognition and psychopathology to functional impairment in schizophrenia.

Authors:  Somaia Mohamed; Robert Rosenheck; Marvin Swartz; Scott Stroup; Jeffrey A Lieberman; Richard S E Keefe
Journal:  Am J Psychiatry       Date:  2008-05-01       Impact factor: 18.112

8.  Prospective comparison of course of disability in antipsychotic-treated and untreated schizophrenia patients.

Authors:  J Thirthalli; B K Venkatesh; K V Kishorekumar; U Arunachala; G Venkatasubramanian; D K Subbakrishna; B N Gangadhar
Journal:  Acta Psychiatr Scand       Date:  2008-11-24       Impact factor: 6.392

9.  Social disability in schizophrenic, schizoaffective and affective disorders 15 years after first admission.

Authors:  Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Journal:  Schizophr Res       Date:  2010-01       Impact factor: 4.939

Review 10.  What are the functional consequences of neurocognitive deficits in schizophrenia?

Authors:  M F Green
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112

View more
  7 in total

1.  Differential diagnosis of major depression and bipolar disorder.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03       Impact factor: 5.270

2.  Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies.

Authors:  Ilja Spellmann; Rebecca Schennach; Florian Seemüller; Sebastian Meyer; Richard Musil; Markus Jäger; Max Schmauß; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Michael Bauer; Mazda Adli; Joachim Zeiler; Wolfram Bender; Klaus-Thomas Kronmüller; Marcus Ising; Peter Brieger; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Michael Riedel; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-10-26       Impact factor: 5.270

3.  Factors predicting the long-term illness course in a cohort of depressed inpatients.

Authors:  Christine Kuehner; Silke Huffziger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-10-30       Impact factor: 5.270

4.  Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients.

Authors:  Suguru Nakajima; Yuko Higuchi; Takahiro Tateno; Daiki Sasabayashi; Yuko Mizukami; Shimako Nishiyama; Tsutomu Takahashi; Michio Suzuki
Journal:  Front Psychiatry       Date:  2021-11-25       Impact factor: 4.157

5.  Emotional reactions to involuntary psychiatric hospitalization and stigma-related stress among people with mental illness.

Authors:  Nicolas Rüsch; Mario Müller; Barbara Lay; Patrick W Corrigan; Roland Zahn; Thekla Schönenberger; Marco Bleiker; Silke Lengler; Christina Blank; Wulf Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-05-21       Impact factor: 5.270

6.  Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders.

Authors:  Federica Pinna; Massimo Tusconi; Marta Bosia; Roberto Cavallaro; Bernardo Carpiniello
Journal:  BMC Psychiatry       Date:  2013-09-26       Impact factor: 3.630

7.  Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances.

Authors:  Federica Pinna; Marta Bosia; Roberto Cavallaro; Bernardo Carpiniello
Journal:  Schizophr Res Cogn       Date:  2014-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.